- Active Pharmaceutical Ingredients
- 酒石酸伐尼克兰
- Aprepitant, Fosapitant Intermediates
- 福沙匹坦双葡甲胺
- 维格列汀
- 艾氟康唑
- Luliconazole Intermediate
- 钆特酸葡胺
- Succinyl Alcohol Intermediate
- Mirabillon Intermediate
- Atazanavir Intermediate
- Intermediate
- 酒石酸伐尼克兰
- 阿瑞匹坦 287930-73-8
- 阿瑞匹坦 127852-28-2
- 阿瑞匹坦 287930-75-0
- 阿瑞匹坦 200000-59-5
- 阿瑞匹坦 155742-64-6
- 阿瑞匹坦 252742-72-6
- 福沙匹坦双葡甲胺 990-91-0
- 福沙匹坦双葡甲胺 265121-01-5
- 维格列汀 207557-35-5
- 维格列汀 702-82-9
- 艾氟康唑 144230-50-2
- 艾氟康唑 133775-25-4
- 艾氟康唑 127000-90-2
- 钆特酸葡胺
- 米拉贝隆
- 卢立康唑 98873-55-3
- 卢立康唑 126534-31-4
- 硫酸阿扎那韦
- 硼替佐米 179324-87-9
- 硼替佐米 114457-94-2
- 硼替佐米 205393-22-2
- 布林佐胺
- 利伐沙 446292-08-6
- 利伐沙 446292-07-5
- 西那卡塞 1005450-55-4
- 西那卡塞 585-50-2
- Eletriptan Intermediate
- 茚达特罗 312753-53-0
- 茚达特罗 173140-90-4
- Sitagliptin Intermediate
- Fosanavir Calcium Intermediate
Popular information
Cinacalcet Intermediate1005450-55-4
【Catalogue Number】AP0910
【CAS #】 1005450-55-4
【Molecular formula】 C22H20F3NO
[Product Introduction] (R)-N-(1-(naphthalene-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide, the English name is N-((R) -1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)-propanamide, American Chemical Abstracts Registry number is cas1005450-55-4.
Cinacalcet Intermediate
N-((R)-1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)-
propanamide
CAS 1005450-55-4
Other Names Cinacalcet Hydrochloride Intermediate
Catalog number AP0910
CAS # 1005450-55-4
Molecular formula C22H20F3NO
Molecular weight 371.4
Structural formula
Product introduction
CAS 1005450-55-4 (R) -N- (1- (naphthalene-1-yl) ethyl) -3- (3- (trifluoromethyl) phenyl) propionamide, the English name is
N-((R) -1- (naphthalen-1-yl) ethyl) -3- (3- (trifluoromethyl) phenyl) -propanamide, American Chemical Abstracts Registration Number is cas1005450-55-4.
This product (cas 1005450-55-4) is an intermediate of cinacalcet hydrochloride. Cinacalcet hydrochloride (cas 226256-56-0) is mainly used to treat secondary hyperparathyroidism in patients with dialysis in renal disease or hypercalcemia caused by parathyroid cancer.
VIWIT 沪ICP备12014533号-1
